title: What is clinically significant RLS and who decides about its treatment?
authors.forename: Klaus
authors.initials: K
authors.lastname: Berger
mesh_terms: D003430:Cross-Sectional Studies; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000819:agonists; D006801:Humans; D012148:Restless Legs Syndrome / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D004295:Dihydroxyphenylalanine